Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayuri Shukla

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Ageing Research Reviews|April 19, 2020
The multi-faceted impact of methamphetamine on Alzheimer's disease: From a triggering role to a possible therapeutic useMayuri Shukla, Bruno Vincent
Neuroscience and Biobehavioral Reviews|October 4, 2021
Methamphetamine abuse disturbs the dopaminergic system to impair hippocampal-based learning and memory: An overview of animal and human investigationsMayuri Shukla, Bruno Vincent
Current Neuropharmacology|March 15, 2023
Melatonin as a Harmonizing Factor of Circadian Rhythms, Neuronal Cell Cycle and Neurogenesis: Additional Arguments for Its Therapeutic Use in Alzheimer's DiseaseMayuri Shukla, Bruno Vincent
Current Neuropharmacology|September 11, 2023
The Common Denominators of Parkinson's Disease Pathogenesis and Methamphetamine AbuseBruno Vincent, Mayuri Shukla
Current Alzheimer Research|June 25, 2020
Melatonin Prevents Neddylation Dysfunction in Aβ42-Exposed SH-SY5Y Neuroblastoma Cells by Regulating the Amyloid Precursor Protein- Binding Protein 1 PathwayMayuri Shukla, Vorapin Chinchalongporn, Piyarat Govitrapong
Journal of Pineal Research|January 21, 2018
Melatonin ameliorates Aβ<sub>42</sub> -induced alteration of βAPP-processing secretases via the melatonin receptor through the Pin1/GSK3β/NF-κB pathway in SH-SY5Y cellsVorapin Chinchalongporn, Mayuri Shukla, Piyarat Govitrapong
Neurochemical Research|February 5, 2022
A Synopsis of Multitarget Potential Therapeutic Effects of Huperzine A in Diverse Pathologies-Emphasis on Alzheimer's Disease PathogenesisMayuri Shukla, Prapimpun Wongchitrat, Piyarat Govitrapong
Annals of the New York Academy of Sciences|February 14, 2019
The role of melatonin in targeting cell signaling pathways in neurodegenerationMayuri Shukla, Vorapin Chinchalongporn, Piyarat Govitrapong, et al.
Biology|September 28, 2024
Melatonin Augments the Expression of Core Transcription Factors in Aged and Alzheimer's Patient Skin FibroblastsMayuri Shukla, Raphiporn Duangrat, Chutikorn Nopparat, et al.
Antioxidants (Basel, Switzerland)|January 6, 2021
Role of Melatonin on Virus-Induced Neuropathogenesis-A Concomitant Therapeutic Strategy to Understand SARS-CoV-2 InfectionPrapimpun Wongchitrat, Mayuri Shukla, Ramaswamy Sharma, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Ageing Research Reviews|April 19, 2020
The multi-faceted impact of methamphetamine on Alzheimer's disease: From a triggering role to a possible therapeutic useMayuri Shukla, Bruno Vincent
Neuroscience and Biobehavioral Reviews|October 4, 2021
Methamphetamine abuse disturbs the dopaminergic system to impair hippocampal-based learning and memory: An overview of animal and human investigationsMayuri Shukla, Bruno Vincent
Current Neuropharmacology|March 15, 2023
Melatonin as a Harmonizing Factor of Circadian Rhythms, Neuronal Cell Cycle and Neurogenesis: Additional Arguments for Its Therapeutic Use in Alzheimer's DiseaseMayuri Shukla, Bruno Vincent
Current Neuropharmacology|September 11, 2023
The Common Denominators of Parkinson's Disease Pathogenesis and Methamphetamine AbuseBruno Vincent, Mayuri Shukla
Current Alzheimer Research|June 25, 2020
Melatonin Prevents Neddylation Dysfunction in Aβ42-Exposed SH-SY5Y Neuroblastoma Cells by Regulating the Amyloid Precursor Protein- Binding Protein 1 PathwayMayuri Shukla, Vorapin Chinchalongporn, Piyarat Govitrapong
Journal of Pineal Research|January 21, 2018
Melatonin ameliorates Aβ<sub>42</sub> -induced alteration of βAPP-processing secretases via the melatonin receptor through the Pin1/GSK3β/NF-κB pathway in SH-SY5Y cellsVorapin Chinchalongporn, Mayuri Shukla, Piyarat Govitrapong
Neurochemical Research|February 5, 2022
A Synopsis of Multitarget Potential Therapeutic Effects of Huperzine A in Diverse Pathologies-Emphasis on Alzheimer's Disease PathogenesisMayuri Shukla, Prapimpun Wongchitrat, Piyarat Govitrapong
Annals of the New York Academy of Sciences|February 14, 2019
The role of melatonin in targeting cell signaling pathways in neurodegenerationMayuri Shukla, Vorapin Chinchalongporn, Piyarat Govitrapong, et al.
Biology|September 28, 2024
Melatonin Augments the Expression of Core Transcription Factors in Aged and Alzheimer's Patient Skin FibroblastsMayuri Shukla, Raphiporn Duangrat, Chutikorn Nopparat, et al.
Antioxidants (Basel, Switzerland)|January 6, 2021
Role of Melatonin on Virus-Induced Neuropathogenesis-A Concomitant Therapeutic Strategy to Understand SARS-CoV-2 InfectionPrapimpun Wongchitrat, Mayuri Shukla, Ramaswamy Sharma, et al.
Pageof 2